[TLX] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
31-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -52.91%
YoY- -208.87%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/01/17 31/12/15 CAGR
Revenue 1,818 195 0 49 0 0 0 -
PBT -17,125 -10,524 -5,190 -4,806 -3,143 -1,594 -66 389.78%
Tax -6,756 1,884 -5,190 -471 -76 -38 -8 586.27%
NP -10,370 -8,640 -5,190 -4,806 -3,143 -1,556 -66 324.36%
Tax Rate - - - - - - - -
Total Cost 12,187 8,835 5,190 4,854 3,143 1,556 66 344.40%
Ratio Analysis
30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/01/17 31/12/15 CAGR
NP Margin -570.54 -4,430.77 0.00 -9,850.62 0.00 0.00 0.00 -
Per Share
30/06/19 31/12/18 30/06/18 31/12/17 30/06/17 31/01/17 31/12/15 CAGR
EPS -0.05 -0.04 -0.03 -0.02 -1.28 -0.01 0.00 -
EPS Diluted -0.05 -0.04 -0.03 -0.02 -1.28 -0.01 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.